Cargando…
TRIM study protocol - a prospective randomized multicenter Trial to assess the Role of Imaging during follow-up after radical surgery of stage IIB-C and III cutaneous malignant Melanoma
BACKGROUND: The incidence of cutaneous malignant melanoma (CMM) is increasing worldwide. In Sweden, over 4600 cases were diagnosed in 2018. The prognosis after radical surgery varies considerably with tumor stage. In recent years, new treatment options have become available for metastatic CMM. Early...
Autores principales: | Naeser, Ylva, Helgadottir, Hildur, Brandberg, Yvonne, Hansson, Johan, Bagge, Roger Olofsson, Elander, Nils O., Ingvar, Christian, Isaksson, Karolin, Flygare, Petra, Nilsson, Cecilia, Jakobsson, Frida, del Val Munoz, Olga, Valachis, Antonis, Jansson, Malin, Sparring, Charlotte, Ohlsson, Lars, Dyrke, Ulf, Papantoniou, Dimitrios, Sundin, Anders, Ullenhag, Gustav J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7720485/ https://www.ncbi.nlm.nih.gov/pubmed/33287744 http://dx.doi.org/10.1186/s12885-020-07632-4 |
Ejemplares similares
-
Quality of Life in the First Year of Follow-Up in a Randomized Multicenter Trial Assessing the Role of Imaging after Radical Surgery of Stage IIB-C and III Cutaneous Melanoma (TRIM Study)
por: Naeser, Ylva, et al.
Publicado: (2022) -
Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study
por: Helgadottir, Hildur, et al.
Publicado: (2023) -
Multiple Primary Melanoma Incidence Trends Over Five Decades: A Nationwide Population-Based Study
por: Helgadottir, Hildur, et al.
Publicado: (2020) -
Isolated Hepatic Perfusion With Melphalan for Patients With Isolated Uveal Melanoma Liver Metastases: A Multicenter, Randomized, Open-Label, Phase III Trial (the SCANDIUM Trial)
por: Olofsson Bagge, Roger, et al.
Publicado: (2023) -
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic uveal melanoma (PEMDAC study): protocol for a multicenter phase II open label study
por: Jespersen, Henrik, et al.
Publicado: (2019)